Modopharma Holding ApS: Financial statements 2022
CVR: 42173622
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Modopharma Holding ApS (CVR 42173622) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,500 and a net result of DKK -16,015 compared with DKK -17,406 the year before. Equity in the 2022 report amounted to DKK 7,249. The solvency ratio was 38.7%.
- Gross Profit
- DKK -6,500
- Profit/Loss
- DKK -16,015
- Equity
- DKK 7,249
- Total Assets
- DKK 18,749
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -7 t. | -16 t. | 7 t. | - |
| 2021 | - | -6 t. | -17 t. | 23 t. | - |
Official annual report
Keep an eye on Modopharma Holding ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Modopharma Holding ApS has published its interim report for the period March 1, 2021 – December 31, 2021.
About Modopharma Holding ApS
Modopharma Holding ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Per Wilken Andersen. The company is owned by Per Wilken Andersen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,500 and a net result of DKK -10,330 compared with DKK -14,894 the year before. Equity in the 2025 report amounted to DKK -31,000.